Research Article
Clinical Impact of EUS-Guided Fine Needle Biopsy Using a Novel Franseen Needle for Histological Assessment of Pancreatic Diseases
| | Group A (N = 50) | Group B (N = 36) | P value |
| Age | | | | median (IQR) | 70.5 (60-75) | 65 (57-77) | 0.546 | Gender | | | | male | 30 | 21 | | female | 20 | 15 | 0.526 | Size of the lesion (mm) | | | | median (IQR) | 30 (20-39.5) | 28 (23-34) | 0.952 | Final diagnosis | | | | Pancreatic adenocarcinoma | 39 | 33 | | Pancreatic metastasis | 3 | 1 | | Mass forming pancreatitis | 3 | 0 | | Neuroendocrine neoplasm | 1 | 1 | | IPMN | 1 | 0 | | ITPN | 1 | 0 | | ALL | 1 | 0 | | SCA | 1 | 0 | | SPN | 0 | 1 | 0.303 |
|
|
IPMN: Intraductal papillary mucinous neoplasm. ITPN: intraductal tubulopapillary neoplasm. ALL: acute lymphoblastic leukemia. SCA: serous cystic adenoma. SPN: solid pseudopapillary neoplasm.
|